How antibiotic allergy labels may be harming our most vulnerable patients.

Trubiano, Jason A; Grayson, M Lindsay; Thursky, Karin A; Phillips, Elizabeth J; Slavin, Monica A

Trubiano, Jason A; Grayson, M Lindsay; Thursky, Karin A; Phillips, Elizabeth J; Slavin, Monica A.

Affiliation

Trubiano JA; Austin Health, Melbourne, VIC Jason.Trubiano@austin.org.au.
Grayson ML; Austin Health, Melbourne, VIC.
Thursky KA; Peter MacCallum Cancer Centre and National Centre for Infections in Cancer, Melbourne, VIC.
Phillips EJ; Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA.
Slavin MA; Peter MacCallum Cancer Centre and National Centre for Infections in Cancer, Melbourne, VIC.

Med J Aust ; 208(11): 469-470, 2018 06 18.

Article in En | MEDLINE | ID: mdl-29902399

Subject(s)

Anti-Bacterial Agents/adverse effects; Drug Hypersensitivity/diagnosis; Drug Labeling/standards; Drug Hypersensitivity/classification; Drug Resistance, Microbial; Global Health; Humans; Penicillins/adverse effects; Risk Factors; Skin Tests; beta-Lactamases/adverse effects

Key words

Adverse drug reactions; Anti-infective agents; Deprescriptions; Drug resistance, microbial; Hypersensitivity

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug Hypersensitivity / Drug Labeling / Anti-Bacterial Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google